<DOC>
	<DOCNO>NCT01876797</DOCNO>
	<brief_summary>This study characterize pharmacokinetic pharmacodynamics ticagrelor prasugrel healthy Korean male subject . The study open label , one sequence , crossover design . In period 1 , single oral dose 180 mg ticagrelor administrate . After least 7 day washout period , period 2 , single oral dose 60 mg prasugrel administrate . After dose period , blood sample PK PD assessment conduct . 1 . Blood Sampling Times 1 . PK : predose,10 min,15 min,25 min , 0.5,1,1.5,2,2.5,4,6,8,12 24h post-dose 2 . PD : predose,15 min,0.5,1,2,4,6,8,12 24h post-dose 2 . Bioanalysis 1. plasma Ticagrelor 2. plasma AR-C124910XX ( active metabolite ticagrelor ) 3. plasma R-95913 ( inactive metabolite prasugrel ) 4. plasma R-13727 ( active metabolite prasugrel ) 3 . Platelet Aggregation Test use turbidometric Method Maximal Platelet Aggregation ( MPA ) 4 . PK-PD Modeling analysis</brief_summary>
	<brief_title>PKPD Study Ticagrelor Prasugrel Healthy Korean Males</brief_title>
	<detailed_description />
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1. male age 19 45 year screen visit 2. body weight least 60 kg screen visit 3. body mass index 18 30 kg/m2 4 . SBP 90 149 mmHg DBP 60 99 mmHg pulse rate ( beat per minute ) 45 100 screen visit 1. history clinically significant abnormality 2. gastrointestinal disorder impact absorption study drug 3. history hypersensitivity ticagrelor prasugrel compound relate study drug 4. history take original medicine within 30 day dose history take prescribed drug within 14 day dose history take OTC drug within 7 day dose 5. history take study drug within 60 day dose 6. history whole blood transfusion within 60 day dose history blood element transfusion history heave transfuse within 30 day 30 day 7. history take metabolic inducer inhibitor 8. overuse ( caffeine : &gt; 5 units/day , alcohol : &gt; 21 unit /week , smoking : &gt; 10 cigarettes/day ) 9. positive serology testy ( Hbs antigen , HIV , Hepatitis C virus , Syphilis ) 10. abnormality clinical laboratory test result ECG finding consider inadequate investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>